DFW Capital has sold Superior Controls to E-Technologies, a portfolio company of Falfurrias Capital
Founded in 1993 and headquartered in Seabrook, New Hampshire, Superior Controls is a leading provider of mission-critical automation, integration and engineering support services to the biotechnology and pharmaceutical sectors. The company’s services are critical to the startup and ongoing support and maintenance of complex, increasingly advanced manufacturing systems. Superior’s engineering talent, institutional know-how and sector expertise position the company’s value proposition at the nexus of accelerating innovation and ensuring compliance with stringent regulatory requirements. The company’s 135+ engineers and national footprint make it the leading full-service automation and systems integrator focused on the life sciences market.
Rick Pierro, Superior’s Chief Executive Officer, commented, “Lincoln’s strong relationships with global strategic acquirers and deep understanding of the engineering services business model enabled us to convey Superior’s uniqueness and compelling value proposition. We are excited to partner with E-Technologies and drive continued future success.”
Lincoln acted as exclusive financial advisor to DFW Capital Partners and Superior, working closely with its shareholders and management team throughout the sale process. This included providing advisory expertise and managing the preparatory, marketing, negotiation and due diligence phases of the transaction.
Lincoln ran a highly disciplined, competitive process that yielded an exceptional result for Superior Controls and its shareholders.
Meet our Senior Team
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical